Epstein Secrets

Date: December 15, 2016 at 10:59:39 AM EST To: "Rich Kahn" Pd Reply-To: "Ens, Amanda" co The US team

the HIX ($14.3bn in 2018), Medtech Tax (2.3%), pharma industry tax ($4.1bn in 2018) & Cadillac tax (effective 2020). As for the views by analysts... Biotech (+) — believe sector will outperform largely as pricing risk has diminished (although will remain in pockets) but pipelines/growth remains. Ying’s to

, F., Lauffenburger, D. A., Whitesides, G. M. and Rich, A., Biomater., 1999, 1213-1220. 648. "Pattern

Micropattemed Surfaces for Control of Cell Shape, Position, and Function", Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M. and Ingber, D. E., Biotech. Frog, 1999, 14, 356.363. 633. "Fabrication of Glassy Carbon Microstructures by Soft Lithography", Schueller, O. 3. A., Brittain, S. T. and Whites

via bullish X-market risk reversals Steet Selling rich USO (WTI tracker) 3M 25d puts to fund cheaper SXE

Nov-12 Feb-13 Aug-13 Nov-13 Feb-14 May-14 Aug-14 Nov-14 Feb-15 Nov-15 Feb-16 May-16 Aug-16 <= ol (A) Chart 12: Near multi-year flat call skew on Biotech (IBB) makes long call spreads an attractive option strategy to initiate or replace long positions to lock-in profits from the recent strong rally 55